Vimal Mehta - 14 May 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
CEO and President, Director
Signature
/s/ Richard Steinhart, as Attorney in Fact for Vimal Mehta
Issuer symbol
BTAI
Transactions as of
14 May 2022
Net transactions value
$0
Form type
4
Filing time
17 May 2022, 15:40:58 UTC
Previous filing
16 Mar 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Restricted Stock Units Award $0 +15,000 $0.000000 15,000 14 May 2022 Common Stock 15,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest and settle on May 14, 2023, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.